Specifically, we compared the expression of miR-210, its target genes (GPD1L and SDHD), HIF-1α, and HIF-1α-responsive genes (EDN2, VEGFA, and SLC2A1) in GLCs from PCOS and normally ovulating women. The gene discussed is SLC2A1; the disease is polycystic ovary syndrome.